Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
05/23/2012 | CN102051275B Novel application of Artemisia rupestris L extract |
05/23/2012 | CN102038820B Prepared Chinese medicine for improving and regulating autoimmune function of hepatitis B virus carriers |
05/23/2012 | CN101999667B Alkali extraction of mung bean flavone and method for preparing flavone mung bean beverage |
05/23/2012 | CN101967442B Barley monascus prepared wine and preparation method thereof |
05/23/2012 | CN101948729B Deer turtle ginseng wine and preparation method thereof |
05/23/2012 | CN101948539B IL-18 binding proteins |
05/23/2012 | CN101928709B Gene sequence, recombinant expression and application of hyalomma asiaticum histamine binding protein (HaHBP) |
05/23/2012 | CN101904885B Medicinal composition for treating allergic rhinitis and preparation method and application thereof |
05/23/2012 | CN101899090B Saturated fatty chain alcohol His-Gly-AA tripeptide ester, synthetic method and application thereof |
05/23/2012 | CN101899087B Saturated fatty chain amine Glu-Asp-Gly tripeptide amides as well as synthesis method and application thereof |
05/23/2012 | CN101899086B Saturated fatty chain acid Glu-Asp-Gly tripeptide amide, synthetic method and application thereof |
05/23/2012 | CN101897768B Drug composition for resisting inflammation and easing pain and preparation method and application thereof |
05/23/2012 | CN101890084B Semen nigellae total glycoside extract and preparation method and application thereof |
05/23/2012 | CN101849986B Immunopotentiator for weaning piglets and application thereof |
05/23/2012 | CN101829303B Longevity wine |
05/23/2012 | CN101798285B Sinomenine derivate, synthesis method and application thereof |
05/23/2012 | CN101766662B Process for efficiently concentrating cordycepin |
05/23/2012 | CN101744975B Method for detecting compound lightyellow sophora root injection |
05/23/2012 | CN101732364B Method for identifying lucid ganoderma alkaloids substance finger-print |
05/23/2012 | CN101711775B Fermentation composition for fermenting Agaricus blazei Murrill through probiotics |
05/23/2012 | CN101690588B Composition comprising probiotics and tea extract and application thereof |
05/23/2012 | CN101549043B Traditional Chinese medicine preparation and preparation method thereof |
05/23/2012 | CN101522670B Pyridin-3-yl derivatives as immunomodulating agents |
05/23/2012 | CN101518594B Anti-tumor immunity-enhancing traditional Chinese medicine preparation and preparation method thereof |
05/23/2012 | CN101171019B Immune function modulating agents |
05/23/2012 | CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
05/22/2012 | US8183363 Antisense oligonucleotide modulation of STAT3 expression |
05/22/2012 | US8183352 Attenuated vif DNA immunization cassettes for genetic vaccines |
05/22/2012 | US8183273 Bicyclic compound, production and use thereof |
05/22/2012 | US8183009 Assaying cellular markers for the evaluation of tumors |
05/22/2012 | US8182821 Flu vaccine admixture of mannan and flu antigen |
05/22/2012 | US8182816 Methods of treating cancer |
05/22/2012 | US8182812 Human monoclonal antibodies against CD25 |
05/22/2012 | CA2660355C Polynucleotide vaccine formulation against pathologies of the horse |
05/22/2012 | CA2648036C Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor |
05/22/2012 | CA2442326C Imidazolyl derivatives useful as histamine h3 receptor ligands |
05/22/2012 | CA2436107C Kyberdrug as autovaccines with immune-regulating effects |
05/22/2012 | CA2274803C Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
05/18/2012 | WO2012064981A2 Methods to test allergic conditions |
05/18/2012 | WO2012064973A2 Heterocyclic compounds and uses thereof |
05/18/2012 | WO2012064222A1 Agent for inducing endogenous interferon |
05/18/2012 | WO2012063357A1 Method for producing bioactive agent, bioactive agent produced thereby, cosmetic, freshness-maintaining agent, growth promotion agent, soil conditioning agent, and pharmaceutical stock solution |
05/18/2012 | WO2012063345A1 Immunopotentiating agent, immunopotentiating composition containing same, and immunopotentiating method |
05/18/2012 | WO2012063272A1 Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd). |
05/18/2012 | WO2012063007A1 Factor h for treating autoimmune diseases of the nervous system |
05/18/2012 | WO2012062900A2 Frozen confections containing probiotic micro-organisms |
05/18/2012 | WO2012062782A1 Non-replicating probiotic bacteria and prevention or treatment of infections to reduce absence from school or daycare |
05/18/2012 | WO2012062157A1 Pyrano[3,2-d]thiazol derivatives and uses thereof as selective glycosidase inhibitors |
05/18/2012 | WO2012062094A1 Conjugate of folate and antibody, preparation method and use thereof |
05/18/2012 | WO2012061972A1 Selective glycosidase inhibitors and uses thereof |
05/18/2012 | WO2012061971A1 Selective glycosidase inhibitors and uses thereof |
05/18/2012 | WO2012015979A3 Hmgb1-derived peptides enhance immune response to antigens |
05/18/2012 | WO2012014085A3 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses |
05/18/2012 | WO2012011992A3 Ricin vaccine and methods of making and using thereof |
05/18/2012 | CA2825083A1 Conjugate of folate and antibody, preparation method and use thereof |
05/18/2012 | CA2817755A1 Modified immune-modulating particles |
05/18/2012 | CA2817709A1 Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same |
05/18/2012 | CA2817694A1 Non-replicating probiotic bacteria and prevention or treatment of infections to reduce absence from school or daycare |
05/18/2012 | CA2817529A1 Frozen confections containing probiotic micro-organisms |
05/18/2012 | CA2816753A1 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases |
05/18/2012 | CA2816722A1 Conjugates of an il-2 moiety and a polymer |
05/18/2012 | CA2813413A1 Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd) |
05/17/2012 | US20120124703 Novel coprinus comatus and tremella mesenterica mushroom strains, products and extracts thereof and compositions comprising them |
05/17/2012 | US20120124683 Delivery method |
05/17/2012 | US20120122972 Novel eicosanoid derivatives |
05/17/2012 | US20120122943 Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents |
05/17/2012 | US20120122942 5-oxo-ete receptor antagonist compounds |
05/17/2012 | US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents |
05/17/2012 | US20120122924 Nampt inhibitors |
05/17/2012 | US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation |
05/17/2012 | US20120122902 Pyrimidine derivative, preparation method and use thereof |
05/17/2012 | US20120122901 Pyrrolo[2,3-d]pyrimidine compounds |
05/17/2012 | US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
05/17/2012 | US20120122894 Inhibitors of bruton's tyrosine kinase |
05/17/2012 | US20120122882 Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors |
05/17/2012 | US20120122879 Compounds useful as protein kinase inhibitors |
05/17/2012 | US20120122862 Arginine derivatives with np-i antagonistic activity |
05/17/2012 | US20120122838 Heterocyclic compounds and uses thereof |
05/17/2012 | US20120122836 Polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylic |
05/17/2012 | US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method |
05/17/2012 | US20120122781 Peptide ligands of somatostatin receptors |
05/17/2012 | US20120122109 Neural progenitor cells derived from embryonic stem cells |
05/17/2012 | US20120121743 Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same |
05/17/2012 | US20120121730 Pharmaceutical and nutraceutical compositions for treating respiratory disease and associated phlegm |
05/17/2012 | US20120121729 Antitussive compositions comprising memantine |
05/17/2012 | US20120121724 Film comprising therapeutic agents |
05/17/2012 | US20120121714 Compositions with antigens adsorbed to calcium phosphate |
05/17/2012 | US20120121713 Chimeric therapeutics, compositions, and methods for using same |
05/17/2012 | US20120121710 Mucosal Immunization |
05/17/2012 | US20120121695 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine |
05/17/2012 | US20120121690 Method to enhance an immune response of nucleic acid vaccination |
05/17/2012 | US20120121689 Small interfering rna delivery |
05/17/2012 | US20120121688 Preventative or therapeutic agent and method for immune disease |
05/17/2012 | US20120121685 Breakfast cereals containing probiotic micro organisms |
05/17/2012 | US20120121668 Compositions for oral adminstration of active principles requiring masking of taste |
05/17/2012 | US20120121652 Complete liquid nutrition for children at the age of 1-10 years comprising probiotics |
05/17/2012 | US20120121651 Pyrazolopyridines and analogs thereof |
05/17/2012 | US20120121650 Chimeric Virus Vaccines |
05/17/2012 | US20120121649 Compositions and methods for the prevention and treatment of cancer |
05/17/2012 | US20120121648 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |